Refining Ethical Guidelines for Early Clinical Trials of Pluripotent Stem-Cell-Derived Therapeutics for Parkinson's Disease

American Journal of Bioethics Neuroscience 6 (1):65-66 (2015)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/21507740.2014.995317

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,571

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
Differentiation of pluripotent stem cells into retinal pigmented epithelium.R. H. Croze & D. O. Clegg - unknown
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Translating Stem Cell Research: Challenges at the Research Frontier.David Magnus - 2010 - Journal of Law, Medicine and Ethics 38 (2):267-276.
Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's Disease.Samia A. Hurst, Alex Mauron, Shahan Momjian & Pierre R. Burkhard - 2015 - American Journal of Bioethics Neuroscience 6 (1):52-60.
Towards guidelines for informed consent for prospective stem cell research.J. Greenberg, D. C. Smith, R. J. Burman, R. Ballo & S. H. Kidson - 2015 - South African Journal of Bioethics and Law 8 (2):46.
Some Ethical Concerns About Human Induced Pluripotent Stem Cells.Yue Liang Zheng - 2016 - Science and Engineering Ethics 22 (5):1277-1284.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Stem Cells Therapy and Research. Benefits and Ethical Challences.Nicolae Ovidiu Grad, Ionel Ciprian Pop & Ion Aurel Mironiuc - 2012 - Journal for the Study of Religions and Ideologies 11 (32):190-205.
Moral complicity in induced pluripotent stem cell research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Which Patient Groups Should Be Asked to Participate in First-in-Human Trials of Stem-Cell-Based Therapies?Kristina Hug & Göran Hermerén - 2012 - Journal of Clinical Ethics 23 (3):256-271.
Bringing prosocial values to translational, disease-specific stem cell research.Reuben G. Sass - 2014 - BMC Medical Ethics 15 (1):16.

Analytics

Added to PP
2018-06-22

Downloads
12 (#1,078,270)

6 months
6 (#509,139)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references